JP Stock MarketDetailed Quotes

2395 Shin Nippon Biomedical Laboratories

Watchlist
  • 1405
  • +36+2.63%
20min DelayMarket Closed Apr 28 15:30 JST
58.49BMarket Cap10.58P/E (Static)

About Shin Nippon Biomedical Laboratories Company

Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Company Profile

Symbol2395
Company NameShin Nippon Biomedical Laboratories
Founded1973-05-18
MarketTSE Prime
Employees1457
Fiscal Year Ends03-31
Address8-1 Akashi-cho
Zip Code891-1394
Phone099-294-2600

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ryoichi Nagata
  • Chairman of the Board, President ,Chief Executive Officer, Chief Health Officer and Director of Fisheries Business
  • --
  • Ken Takanashi
  • Director and Vice President
  • --
  • Dr. Ichiro Nagata
  • Director and Executive Vice President
  • --
  • Dr. Hideshi Tsusaki
  • Director and Senior Managing Director
  • --
  • Keiko Toya
  • Independent Director
  • --
  • Chizuru Matsueda
  • Independent Director
  • --
  • Tsuyoshi Hanada
  • Independent Director
  • --
  • Takashi Yamashita
  • Independent Director
  • --
  • Shinichi Fukumoto
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More